EcoDrugPlus

Metabotropic Glutamate Receptor 3-Like

Ensembl ID : ENSCSEG00000004194
Gene Symbol: LOC103380084
3 Cross references
212 Possible Orthologues:

Metabotropic Glutamate Receptor 5-Like

Ensembl ID : ENSCSEG00000017162
Gene Symbol: LOC103395387
3 Cross references
212 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSCSEG00000004778
Gene Symbol: METAP2
4 Cross references
229 Possible Orthologues:

Microtubule-Associated Protein Tau

Ensembl ID : ENSCSEG00000009557
Gene Symbol: LOC103381620
2 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSCSEG00000007709
Gene Symbol: MAPK1
2 Cross references
190 Possible Orthologues:

Mitogen-Activated Protein Kinase 1-Like

Ensembl ID : ENSCSEG00000019114
Gene Symbol: LOC103397828
3 Cross references
206 Possible Orthologues:

Mitogen-Activated Protein Kinase 1-Like

Ensembl ID : ENSCSEG00000017634
Gene Symbol: LOC103393219
3 Cross references
198 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSCSEG00000018779
Gene Symbol: LOC103390257
3 Cross references
221 Possible Orthologues:

Mitogen-Activated Protein Kinase 11-Like

Ensembl ID : ENSCSEG00000015651
Gene Symbol: LOC103382962
3 Cross references
200 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSCSEG00000001770
Gene Symbol: MAPK14
3 Cross references
191 Possible Orthologues:

Mitogen-Activated Protein Kinase 14a

Ensembl ID : ENSCSEG00000005124
Gene Symbol: LOC103386138
3 Cross references
186 Possible Orthologues:

Mitogen-Activated Protein Kinase 8

Ensembl ID : ENSCSEG00000020330
Gene Symbol: MAPK8
3 Cross references
222 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).